Popular Trials
Behavioural Intervention
Integrated Treatment for Smoking Cessation After Acute Coronary Syndrome
Recruiting1 award7 criteria
Minneapolis, Minnesota
This trial will test whether a single, integrated treatment that targets both depressed mood and smoking is more effective than usual care in reducing post-acute coronary syndrome mortality.
Behavioral Intervention
VLNC Messages for Smoking
Recruiting1 award1 criteria
Atlanta, Georgia
"This trial aims to see how a campaign about reduced nicotine cigarettes, along with using very low nicotine cigarettes, impacts smoking habits and beliefs in adult smokers. They want to see if the messages are effective in
Behavioural Intervention
Smoking Cessation Treatment for Head & Neck Cancer Patients
Recruiting1 awardPhase < 1
Houston, Texas
This trial is designed to study and compare the effectiveness of two types of counseling for cancer patients who want to quit smoking: Acceptance and Commitment Therapy (ACT) and Motivational and Behavioral Counseling (MBC).
Health Literacy Interventions for Smoking
Recruiting1 award
Houston, Texas
This trial is examining whether different types of messages emphasizing the health consequences of smoking, written at a 5th to 6th grade reading level, will have different effects on smokers with varying levels of health literacy.
Popular Filters
Trials for Smoking Cessation Patients
Behavioural Intervention
TMS for Smoking Cessation in Schizophrenia
Recruiting1 award2 criteria
Baltimore, Maryland
This trial uses a magnetic pulse device to help people with schizophrenia stop smoking. It targets specific brain areas involved in both conditions. The goal is to see if this method is effective for this particular group. This method has been shown to decrease cigarette consumption in schizophrenia patients.
Behavioral Intervention
Smoke-Free Policy Support for Smoking Cessation
Recruiting1 award4 criteria
New York, New York
This trial will test two ways to reduce exposure to secondhand smoke in residential buildings. One targets all building residents, while the other targets smokers specifically, with the goal of reducing smoking and exposure to secondhand smoke.
Behavioral Intervention
Digital Coaching for Smoking Cessation
Recruiting1 award1 criteria
San Francisco, California
"This trial aims to test a digital coaching program that uses a chatbot to help people quit smoking by providing motivation, education, and personalized quit plans to overcome social barriers."
Trials for Smoking Addiction Patients
Behavioural Intervention
TMS for Smoking Cessation in Schizophrenia
Recruiting1 award2 criteria
Baltimore, Maryland
This trial uses a magnetic pulse device to help people with schizophrenia stop smoking. It targets specific brain areas involved in both conditions. The goal is to see if this method is effective for this particular group. This method has been shown to decrease cigarette consumption in schizophrenia patients.
Sleep Management for Nicotine Addiction
Recruiting1 award6 criteria
Birmingham, Alabama
This trial will test the hypothesis that chronotype (preference for morning or evening activity) and impaired sleep impact cigarette usage, smoking dependence, urge/craving, and withdrawal differently in blacks compared to whites.
Behavioural Intervention
Transcranial Magnetic Stimulation for Smoking Addiction
Recruiting1 award1 criteria
Newark, New Jersey
This trial aims to find the best way to use brain stimulation to help smokers by testing different protocols. They will also assess how these protocols affect decision-making and cravings. The study will involve two sessions and
Phase 3 Trials
Behavioral Intervention
Withdrawal Regulation Training for Smoking Cessation
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial will test a new smoking cessation treatment to see if it is effective and how it works. The results could help improve existing treatments and reduce smoking-related deaths in the US.
Trials With No Placebo
Nicotine Replacement Therapy
E-Cigarettes + NRT and Counseling for Smoking in Opioid Use Disorder
Recruiting1 awardPhase 2
New York, New York
This trial will compare e-cigarettes with NRT + counseling to help reduce smoking among people in opioid use disorder treatment. It will help provide a tool to reduce tobacco harm in a hard-to-treat population.
NMDA Receptor Antagonist
Ketamine vs Midazolam for Tobacco Use Disorder
Recruiting1 awardPhase < 1
Winston-Salem, North Carolina
This trial tests how different drugs affect smoking habits and cravings in people who are not trying to quit. Participants receive an injection of either ketamine, midazolam, dexmedetomidine, or a saltwater solution. The study aims to see if these drugs can help reduce cravings and withdrawal symptoms.
Behavioural Intervention
TMS for Smoking Cessation in Schizophrenia
Recruiting1 award2 criteria
Baltimore, Maryland
This trial uses a magnetic pulse device to help people with schizophrenia stop smoking. It targets specific brain areas involved in both conditions. The goal is to see if this method is effective for this particular group. This method has been shown to decrease cigarette consumption in schizophrenia patients.
Behavioral Intervention
Smoke-Free Policy Support for Smoking Cessation
Recruiting1 award4 criteria
New York, New York
This trial will test two ways to reduce exposure to secondhand smoke in residential buildings. One targets all building residents, while the other targets smokers specifically, with the goal of reducing smoking and exposure to secondhand smoke.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.